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THE systemic injection of high doses of antigen into a
preimmunized animal results in transient unresponsive-
ness of cell-mediated immune responses. This phenome-
non is known as desensitization. Serum interleukin 2
(IL-2) activity was found transiently in desensitized mice
at 3 h after the antigen challenge. These mice could not
reveal antigen nonspecific delayed-type hypersensitivity
(DTH) 1 d after the challenge. Specific suppression of
DTH was observed at later stages. Sera from 3 h desensi-
tized mice showed suppressive effects on DTH in preo
immunized mice. Administration ofrecombinant IL-2 into
preimmunized mice led to the failure of development of
DTH to antigens. These observations suggest that IL-2
plays an important role in the suppressive environment.
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Introduction
Desensitization of delayed-type hypersensitivity
(DTH) refers to the transient loss of reactivity to
antigen(s) observed in preimmunized animals
following systemic administration of a large amount
of antigen.
1-s When animals sensitized with two or
more antigens are desensitized by the intravenous
injection of one of the immunizing antigens without
adjuvant, DTH to this antigen is reduced or ablated
(specific desensitization). 1’2 In addition, there is a
marked reduction in skin reactivity after challenge
with other antigen(s) to which the animals have
been immunized, but not desensitized (nonspecific
desensitization).
3-s Previous studies have shown
that desensitization is a multistage process,
s-7
involving an initial overpopulation of lymphokines
such as migration inhibition factor, followed by
inhibition of lymphokine production.
The present study was conducted to explore the
suppressive environment in desensitized mice by
using passive transfer of sera or lymph node cells.
Furthermore, the restoration of the immunosup-
pression by the administration of exogenous IL-2
and/or by an IL-2 dependent antigen-reactive T
lymphocyte clone mediating in vivo DTH has been
attempted.
Materials and Methods
Immunization/desensitization" Methylated bovine serum
albumin (MBSA) was purchased from Sigma, St
(C) 1993 Rapid Communications of Oxford Ltd
Louis, MO. Purified protein derivative (PPD) was
purchased from Connaught Laboratories, Willow-
dale, Ontario, Canada. Female BALB/c mice
(Charles River Japan, Tokyo, 6-10 weeks of
age) were immunized with 125 #g MBSA emulsified
in complete Freund’s adjuvant (Difco, Detroit, MI)
containing 2mg/ml of heat-killed Mycobacterium
tuberculosis,s-l Ten days after immunization, mice
were desensitized by injection with a total of 1.5 mg
MBSA (0.5 mg i.v. and 1 mg i.p.) as described
previously.
Cutaneous DTH responses: Mice were challenged with
40/g/0.02 ml antigen (MBSA or PPD) into the
hind footpad.8’ The difference of footpad thickness
at 24 h after and just before challenge injection was
measured. Measurements were made in triplicate for
each mouse tested by using an engineer’s
micrometer (Starret, Athol, MA), and the mean
swelling (mm) + S.E.M. was calculated.<
Transfer oflymph node cells and MBSA-reactive cloned T cells:
Draining lymph nodes were removed from donor
mice and single cell suspensions were prepared.’1
The cells showed 90-95% viability as assessed by
trypan blue dye exclusion. Recipient mice were
given 5 x 107 cells/0.5 ml intravenously. An IL-2
dependent MBSA-reactive T lymphocyte clone
from BALB/c mice immunized with MBSA has
been established.2 The cells are capable of
mediating in vivo MBSA-induced DTH response in
naive syngeneic mice in the presence of both MBSA
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and IL-2. Surface markers of the cells were CD4+.
In brief, MBSA-reactive T-cell suspensions
(1 x 10 cells/0.02 ml) were injected into the hind
footpads of desensitized mice together with IL-2
(4 U) and MBSA (40 #g). Recipient mice were
challenged with antigens for DTH within 1 h of the
transfer. The swelling was measured 24 h after the
challenge.
Serum transfer: Recipient mice were injected with
0.5 ml of serum intravenously. The treatment was
given on the tenth or thirteenth day after
immunization, and then recipients were tested for
DTH.
IL-2:IL-2 activity was measured by a standard IL-2
assay
13 using cytotoxic T-lymphocyte line (CTLL)
(kindly supplied from Dr K. A. Smith, Department
of Medicine, Dartmouth Medical School, Hanover,
NH), and the activity was expressed as half-maxi-
mal units/ml. Recombinant human IL-2 (specific
activity, 1 x 107 U/mg, a gift from Shionogi
Pharmaceutical Co., Osaka, Japan) was injected
subcutaneously into mice. Footpads were chal-
lenged with MBSA or PPD within 1 h following
the injection and 24 h swelling was then measured.
Statistical analysis: Analysis of variance (ANOVA)
was used to determine the statistical significance
between experimental and control groups; p values
less than 0.05 were considered significant.
Results
Failure of antigen-induced footpad responses in desensitized
mice" As shown in Fig. 1, a significant lack of
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FIG. 1. Suppression of footpad responses in desensitized mice.
Immunized mice were challenged with MBSA (immunized-MBSA) and
PPD (immunized-PPD). Desensitized mice were challenged similarly.
Significant suppression, *p < 0.02, p < 0.01.
footpad responses elicited by either MBSA (78-
80% suppression) or PPD (83-89% suppression)
was seen in desensitized mice at 1 d after
desensitization when compared to immunized mice.
Subsequently, abrogation of MBSA (59% suppres-
sion) but not PPD (7% suppression) induced
responses was found in desensitized mice from day
3 through day 7. Thus, desensitization of cutaneous
DTH is composed of antigen nonspecific and
specific stages.
Adoptive transfer ofmph node cells: As shown in Table
1, recipient immunized mice given lymph node cells
either from 3 or 24 h desensitized mice showed
control levels of footpad swelling. In contrast,
MBSA (36% inhibition) but not PPD induced
footpad responses were suppressed in recipient mice
injected with ceils of 72 h desensitized mice. No
suppression of MBSA and PPD induced DTH was
observed when lymph node cells from Oh
Table 1. Adoptive lymph node cell transfer between desensitized and immunized mice
Donor Recipient Footpad swelling (mm _+ S.E.M.) in
recipient mice
Desensitized Immunized MBSA PDD
3 h Immunized 0.54 _+ 0.08 (0%)
b 0.24 _+ 0.03 (12%)
3 h Immunized 0.55 _+ 0.06 (2%) 0.29 _+ 0.02 (-7%)
24 h Immunized 0.51 _+ 0.04 (6%) 0.26 _+ 0.01 (4%)
24 h Desensitized 0.13 _+ 0.02 (76%) 0.09 _+ 0.02 (67%)
Immunized 0.54 _+ 0.03 0.27 ___
0.03
Desensitized 0.10 -t- 0.04 (81%) 0.05 -I- 0.03 (81%)
72 h Immunized 0.36 _+ 0.06 (36%) 0.26 ___
0.01 (-8%)
72 h Desensitized 0.29 _+ 0.01 (49%) 0.24 _+ 0.02 (0%)
Immunized 0.57 ___
0.04 0.24 _+ 0.03
Desensitized 0.24 ___
0.04 (58%) 0.25 _+ 0.03 (-4%)
Lymph node cells (5 x 107 cells/0.5 ml) from desensitized or immunized mice were transferred
into immunized or desensitized mice. Footpads of these mice were challenged with antigens
within h after the transfer and the 24 h footpad swelling was then determined. Data represent
the mean swelling (mm)-I-S.E.M. from three separate experiments of three mice per each
condition.
b Numbers in parentheses indicate percent suppression of footpad swelling as compared to those
of control immunized mice.
Significant suppression (p < 0.01 was observed as compared to footpad swelling of control
immunized mice.
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Table 2. Antigen nonspecific suppression of DTH by endogenous L-2 containing serum
injected into immunized mice
Serum Time (h) after
from desensitization
mice
Footpad response (mean mm _
S.E.M.) in
recipient mice
MBSA PPD
Desensitized 3 0.35 _+ 0.04b (42%) 0.20 _+ 0.05b (44%)
Immunized 3 0.65 +_ 0.04 (-8%) 0.36 _+ 0.01 (0%)
Nonimmunized 3 0.59 _+ 0.03 (2%) 0.38 _+ 0.05 (-6%)
Desensitized 24 0.54 _+ 0.03 (10%) 0.33 _+ 0.04 (8%)
Immunized 24 0.56 _+ 0.06 (7%) 0.32 _+ 0.05 (12%)
Nonimmunized 24 0.62 _+ 0.10 (-3%) 0.35 -I- 0.03 (3%)
Desensitized 72 0.35 _+ 0.01 b (42%) 0.34 _+ 0.05 (6%)
Immunized 72 0.62 +_ 0.06 (-3%) 0.35 +_ 0.06 (3%)
Nonimmunized 72 0.63 _+ 0.08 (- 5%) 0.37 _+ 0.04 (-3%)
Normal mice 0.55 +_ 0.03 (9%) 0.37 +_ 0.08 (-3%)
None 0.60 -I- 0.09 0.36 _+ 0.05
Sera were injected intravenously into recipient immunized mice (0.5 ml i.v./recipient
mouse). Serum 3 h desensitized mice contained endogenous IL-2 activity (50-65 U/ml).
As controls, serum obtained from immunized mice injected with saline was used,
nonimmunized mice injected with MBSA (1.5 mg/mouse), or normal BALB/c mice.
Such control sera showed no IL-2 activity. Data represent the mean footpad swelling
(mm) -t- S.E.M. from three separate experiments of four mice per each condition. Serum
pooled from 10 to 20 mice was used in each experiment.
b Significant suppression (p < 0.01) when compared to immunized mice without
injection of serum.
Values in parentheses indicate percent suppression of footpad swelling when compared
to controls.
desensitized mice were transferred into immunized
mice (data not shown). Lymph node cells from
immunized mice were capable of transferring
DTH into nonimmunized mice. Alternatively, no
effect was found by cell transfer from desensitized
or immunized mice to desensitized mice.
Transfer of suppression of DTH by sera: As shown in
Table 2, serum from 3 h desensitized mice was
capable of inhibiting DTH induced by either MBSA
or PPD (42-44%) in immunized mice. The
suppression was not due to residual antigen in
donor mouse serum since the suppression was
antigen nonspecific and 3 h serum from non-
immunized mice injected with MBSA showed no
inhibition. Sera of 3 h desensitized mice contained
endogenous IL-2 (Fig. 2). The activity was
induced in MBSA preimmunized mice challenged
with MBSA but not with unrelated antigen (egg
albumin and keyhole limpet haemocyanin). Immu-
nization procedures themselves could not induce
the IL-2 activity since the serum from sensitized
mice challenged with saline showed no IL-2
activity. Furthermore, MBSA itself had no effects
on release of serum IL-2 activity because the serum
from nonimmunized mice injected with MBSA did
not contain IL-2 activity. Similar results were
obtained by using mice immunized with other
antigens and desensitized with the respective
antigen. Thus, administration of a large amount of
antigen into immunized mice could induce serum
IL-2 transiently. In contrast, serum from naive,
immunized and 24 h desensitized mice had no et:fects
on DTH immunized mice.
Inhibition of cutaneous DTH by in vivo administration of
exogenous IL-2: As shown in Table 3, preimmunized
mice treated with recombinant IL-2 exhibited
antigen nonspecific suppression of footpad re-
sponses induced by either MBSA or PPD in a
dose-dependent fashion. Suppression of DTH was
observed when mice were injected with _> 50 U of
IL-2 per mouse but not with 10 U. To confirm the
suppressive eects of excess IL-2 on DTH,
"
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FIG. 2. Serum IL-2 activity in desensitized mice. Because CTLL could
respond to IL-4 and IL-2, anti-lL-2 receptor (Boehringer Mannheim
Biochemica, Indianapolis, IN) and anti-murine IL-4 monoclonal
antibodies (TexStar, Dallas, TX) were used to confirm IL-2. The serum
activity of 3 h desensitized mice was inhibited by anti-lL-2 receptor
antibody but not by anti-lL-4 antibody. No detectable IL-2 activity was
found in sera of immunized mice injected with saline and naive mice
challenged with MBSA.
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Table 3. Failure to restore the impaired footpad response in desensitized mice
by exogenous IL-2
Mice Units Swelling (mean mm ___
S.E.M.)
MBSA PPD
Immunized
Desensitized
3h
Desensitized
72h
500 0.23 _+ 0.06 (63%)
b 0.14 -I- 0.04 (55%)
100 0.34 _+ 0.08 (46%) 0.18 _
0.05 (45%)
50 0.36 +_ 0.05 (43%) 0.20 -t- 0.06 (33%)
10 0.51 + 0.07 (19%) 0.26 _+ 0.08 (21%)
0 0.63 _+ 0.08 0.31 -t- 0.06
500 0.12 _+ 0.07 (82%)
b 0.02 __+ 0.08 (94%)
b
100 0.10 -I- 0.09 (85%)
b 0.03 -t- 0.07 (91%)
b
50 0.14 _+ 0.10 (79%)
b 0.05 -t- 0.08 (85%)
b
10 0.13 _+ 0.09 (81%)
b 0.03 + 0.09 (91%)
b
0 0.10 +_ 0.06 (85%)
b 0.04 +__ 0.03 (91%)
b
500 0.26 -I- 0.07 (62%) 0.06 -!- 0.08 (82%)
b
100 0.27 +_ 0.09 (60%) 0.08 +_ 0.07 (76%)
b
50 0.30 _+ 0.10 (55%) 0.05 __+ 0.08 (85%) I
10 0.30 _+ 0.09 (55%) 0.10 _+ 0.09 (70%)
b
0 0.28 + 0.02 (58%) 0.29 + 0.01 (12%)
Data represent the mean mm +_ S.E.M. from three different experiments of three
mice per each condition. Values in parentheses indicate percent suppression of
footpad response.
b Significant suppression, p < 0.01.
Significant suppression, p < 0.02.
recombinant IL-2 was injected into desensitized
mice. As shown in Table 3, administration of
recombinant IL-2 was unable to restore the
suppression of both antigen specific (MBSA) and
nonspecific (PPD) DTH in desensitized mice.
Incapability of transferring DTH in desensitized mice by the
clonedMBSA reactive T cells: As shown in Table 4, the
cell clone was incapable of transferring MBSA
induced DTH in desensitized mice at both early and
later stages of desensitization.
Discussion
In this study, it has been demonstrated that there
are two stages of desensitization. These include
antigen nonspecific desensitization at an early stage
(day 1) and antigen specific desensitization at a later
stage (days 3-7). Also, it has been shown that
serum IL-2 activity transiently appeared in the mice
3 h after desensitization, and that, in a subsequent
step, these mice were unable to express T-cell-
mediated immune responses such as DTH.
Table 4. In vivo administration of MBSA-reactive T-lymphocytes mediating DTH is
unable to induce antigen-specific footpad swelling in desensitized mice
Time after Injection of
desensitization T-cellsb
Footpad swelling (mean mm _
S.E.M.)
MBSA PPD
Oh
Desensitized + 0.09 _+ 0.01 (82%) 0.07 _+ 0.02 (79%)
Desensitized 0.06 -t- 0.03 (88%) 0.05 _+ 0.01 (85%)
Immunizedd + 0.50 _+ 0.07 (0%) 0.32 _+ 0.05 (6%)
Immunized 0.50 _+ 0.02 0.34 _
0.04
72h
Desensitized + 0.24 -I- 0.04 (51%) 0.29 _+ 0.05 (9%)
Desensitized 0.29 _+ 0.02 (41%) 0.31 _+ 0.06 (3%)
Immunized + 0.47 _+ 0.02 (4%) 0.33 _+ 0.07 (0%)
Immunized 0.49 _+ 0.02 0.32 _+ 0.05
The MBSA-reactive T-lymphocyte clone (1 x 105 cells/0.02 ml) was injected into
the footpads of desensitized mice along with MBSA (40#g/0.02ml) and IL-2
(4 U/0.02 ml). Data represent the mean swelling (mm) _+ S.E.M. from three separate
experiments of three mice per each condition. Similar results were obtained from 24 h
desensitized mice injected with the cloned T cells.
b The T-cells could induce footpad swelling response to MBSA in nonimmunized mice
in the presence of IL-2 and MBSA, 0.24 _+ 0.03 mm. The cells were unable to induce
PPD-induced footpad swelling in nonimmunized mice, 0.08 _
0.02 mm.
Values in parentheses show percentage suppression of footpad swelling as compared
to control immunized mice.
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Administration of recombinant IL-2 into pre-
immunized mice induced antigen nonspecific
suppression of DTH. In addition, neither exogen-
ous IL-2 nor cloned antigen reactive T-cells could
restore DTH in desensitized mice. These results
suggest that IL-2-dependent regulatory mechanisms
are responsible for the immunosuppression in
desensitized mice.
The exact mechanisms of desensitization ofDTH
still remain unknown. There are several possibilities
to explain the suppressive mechanisms by induction
of suppressor cells,
14 antigen-mediated interference
with eector cell function,2’15’16 and compartmenta-
lization of effector cells.
17 The nature of passive
transfer of desensitization states by serum or
immunologically competent cells remains con-
troversial. Previous studies on antigen nonspecific
desensitization of immunized guinea-pigs suggest
that the suppression of DTH is due to several
lymphokine-dependent mechanisms. 5-7’18 In fact,
exogenous administration of lymphokines such as
migration inhibition factor into immunized animals
was capable of inducing the passive antigen
nonspecific desensitization. 5-7’18 Antigen nonspecific
DTH was inhibited by administration of sera
containing endogenous IL-2 and recombinant IL-2
(Tables 2 and 3). Also, suppressed DTH in
desensitized mice was unable to be restored by
recombinant IL-2 (Table 3). Administration of
exogenous IL-2 into cancer patients showed
inhibition of DTH. 19’2 Taken together, the
suppression of such mice may be mediated by
lymphokine-dependent suppression mechanisms.
Therefore, it was shown that the suppressed DTH
could not be restored by administration of IL-2
and/or an IL-2 dependent antigen-reactive T cells.
It has been reported that exposure of cloned
helper T-lymphocytes to IL-2 can induce the
antigen unresponsive state, and that unresponsive
helper T-lymphocytes are markedly impaired in
their ability to produce IL-2 after antigenic
restimulation.
21 This may support the present
results that loss of helper cell activity is responsible
for antigen nonspecific desensitization by excess
IL-2 in sera. These two suppressive components
including lymphokine-dependent mechanisms and
loss of helper cells observed in desensitized mice at
the early stage (nonspecific desensitization) may be
closely related. Because type 1 helper T-lympho-
cytes producing IL-2 are responsible for classical
cell-mediated CD4+ functions such as DTH,22’23 it
is possible to assume that the interaction between
soluble mediators and cells leads to the suppressive
environment in the early stage of desensitization.
By contrast, antigen specific desensitization of
DTH may be caused by antigen specific suppressor
cells in lymph nodes of desensitized mice at later
stage. Suppressor cells may be able to generate
suppressor factor(s) into the serum, because the
experiment of serum transfer from 72 h desensitized
mice to immunized mice could inhibit specific DTH
response to desensitized antigen (MBSA) but not
immunized antigen (PPD). Again, neither exoge-
nous IL-2 nor antigen reactive cloned T-cells could
restore antigen specific DTH in desensitized mice
at this stage. In the early stage of desensitization, a
large amount of circulating serum IL-2 was found.
It is known that IL-2 can induce suppressor
cells.24’25 It has been suggested that exposure of
helper T-cells to exogenous IL-2 induces un-
responsiveness to antigenic restimulation
26 and
inhibits IL-2 production.
21 These findings may
suggest that antigen nonspecific desensitization
(early stage) is a prerequisite for the induction of
antigen specific desensitization (later stage). The
mechanisms of desensitization of cutaneous DTH
may be composed of complicated immunological
events such as an IL-2/lymphokine dependent
regulatory system and loss of helper cell function.
A soluble lymphocyte mediator, presumably 1L-2,
may play a central role in the development of the
suppressive environment found in desensitized
mice.
The desensitization of DTH mimics the state of
clinical anergy seen in various human granuloma-
tous
27 and lymphoproliferative diseases.
28 Interest-
ingly, it is possible to demonstrate circulating
lymphokines in the face of cutaneous unresponsive-
ness in human patients27’28 and experimental
animals5’8’1’29 with these conditions. As mentioned
above, this model is useful for investigating
regulation ofDTH as well as the role ofIL-2 in vivo.
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